298 related articles for article (PubMed ID: 31333317)
1. Botulinum toxin injections after surgery for Hirschsprung disease: Systematic review and meta-analysis.
Roorda D; Abeln ZA; Oosterlaan J; van Heurn LW; Derikx JP
World J Gastroenterol; 2019 Jul; 25(25):3268-3280. PubMed ID: 31333317
[TBL] [Abstract][Full Text] [Related]
2. Intrasphincteric botulinum toxin injections for post-operative obstructive defecation problems in Hirschsprung disease: A retrospective observational study.
Roorda D; Oosterlaan J; van Heurn E; Derikx J
J Pediatr Surg; 2021 Aug; 56(8):1342-1348. PubMed ID: 33288128
[TBL] [Abstract][Full Text] [Related]
3. Outcome after anal intrasphincteric Botox injection in children with surgically treated Hirschsprung disease.
Han-Geurts IJ; Hendrix VC; de Blaauw I; Wijnen MH; van Heurn EL
J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):604-7. PubMed ID: 25000353
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin is efficient to treat obstructive symptoms in children with Hirschsprung disease.
Wester T; Granström AL
Pediatr Surg Int; 2015 Mar; 31(3):255-9. PubMed ID: 25616563
[TBL] [Abstract][Full Text] [Related]
5. The utilization of botulinum toxin for Hirschsprung disease.
Svetanoff WJ; Lim-Beutal IIP; Wood RJ; Levitt MA; Rentea RM
Semin Pediatr Surg; 2022 Apr; 31(2):151161. PubMed ID: 35690464
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-guided intrasphincteric botulinum toxin injection relieves obstructive defecation due to Hirschsprung's disease and internal anal sphincter achalasia.
Church JT; Gadepalli SK; Talishinsky T; Teitelbaum DH; Jarboe MD
J Pediatr Surg; 2017 Jan; 52(1):74-78. PubMed ID: 27836361
[TBL] [Abstract][Full Text] [Related]
7. Impact of Botulinum Toxin on Hirschsprung-Associated Enterocolitis After Primary Pull-Through.
Rentea RM; Noel-MacDonnell JR; Bucher BT; Dorman MR; Lautz TB; Pruitt LCC; Oyetunji TA
J Surg Res; 2021 May; 261():95-104. PubMed ID: 33422904
[TBL] [Abstract][Full Text] [Related]
8. Neurostimulation-guided Anal Intrasphincteric Botulinum Toxin Injection in Children With Hirschsprung Disease.
Louis-Borrione C; Faure A; Garnier S; Guys JM; Merrot T; Héry G; Dariel A
J Pediatr Gastroenterol Nutr; 2019 Apr; 68(4):527-532. PubMed ID: 30444834
[TBL] [Abstract][Full Text] [Related]
9. Histology and function of the internal anal sphincter after injection of botulinum toxin.
Langer JC; Birnbaum EE; Schmidt RE
J Surg Res; 1997 Dec; 73(2):113-6. PubMed ID: 9441803
[TBL] [Abstract][Full Text] [Related]
10. Preliminary experience with intrasphincteric botulinum toxin for persistent constipation after pull-through for Hirschsprung's disease.
Langer JC; Birnbaum E
J Pediatr Surg; 1997 Jul; 32(7):1059-61; discussion 1061-2. PubMed ID: 9247234
[TBL] [Abstract][Full Text] [Related]
11. Functional outcomes in Hirschsprung disease: A single institution's 12-year experience.
Thakkar HS; Bassett C; Hsu A; Manuele R; Kufeji D; Richards CA; Agrawal M; Keshtgar AS
J Pediatr Surg; 2017 Feb; 52(2):277-280. PubMed ID: 27912977
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin injection for internal anal sphincter achalasia after pull-through surgery in Hirschsprung disease.
Youn JK; Han JW; Oh C; Kim SY; Jung SE; Kim HY
Medicine (Baltimore); 2019 Nov; 98(45):e17855. PubMed ID: 31702647
[TBL] [Abstract][Full Text] [Related]
13. Outpatient Botulinum Injections for Early Obstructive Symptoms in Patients with Hirschsprung Disease.
Svetanoff WJ; Briggs K; Fraser JA; Lopez J; Fraser JD; Juang D; Aguayo P; Hendrickson RJ; Snyder CL; Oyetunji TA; St Peter SD; Rentea RM
J Surg Res; 2022 Jan; 269():201-206. PubMed ID: 34587522
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of botulinum toxin for internal anal sphincter hypertonicity in children with Hirschsprung's disease.
Minkes RK; Langer JC
J Pediatr Surg; 2000 Dec; 35(12):1733-6. PubMed ID: 11101725
[TBL] [Abstract][Full Text] [Related]
15. Anal sphincter botulinum toxin injection in children with functional anorectal and colonic disorders: A large institutional study and review of the literature focusing on complications.
Halleran DR; Lu PL; Ahmad H; Paradiso MM; Lehmkuhl H; Akers A; Hallagan A; Bali N; Vaz K; Yacob D; Di Lorenzo C; Levitt MA; Wood RJ
J Pediatr Surg; 2019 Nov; 54(11):2305-2310. PubMed ID: 31060739
[TBL] [Abstract][Full Text] [Related]
16. Intrasphincteric botulinum toxin decreases the rate of hospitalization for postoperative obstructive symptoms in children with Hirschsprung disease.
Patrus B; Nasr A; Langer JC; Gerstle JT
J Pediatr Surg; 2011 Jan; 46(1):184-7. PubMed ID: 21238663
[TBL] [Abstract][Full Text] [Related]
17. Topical nitric oxide treatment after pull through operations for Hirschsprung disease.
Tiryaki T; Demirbağ S; Atayurt H; Cetinkurşun S
J Pediatr Gastroenterol Nutr; 2005 Mar; 40(3):390-2. PubMed ID: 15735503
[TBL] [Abstract][Full Text] [Related]
18. Transanal rectal mucosectomy and partial internal anal sphincterectomy for Hirschsprung's disease.
Zhang JS; Li L; Hou WY; Liu SL; Diao M; Zhang J; Ming AX; Cheng W
J Pediatr Surg; 2014 May; 49(5):831-4. PubMed ID: 24851780
[TBL] [Abstract][Full Text] [Related]
19. Comparison of botulinum toxin injection and lateral internal sphincterotomy for the treatment of chronic anal fissure.
Menteş BB; Irkörücü O; Akin M; Leventoğlu S; Tatlicioğlu E
Dis Colon Rectum; 2003 Feb; 46(2):232-7. PubMed ID: 12576897
[TBL] [Abstract][Full Text] [Related]
20. Prevention and management of recurrent postoperative Hirschsprung's disease obstructive symptoms and enterocolitis: Systematic review and meta-analysis.
Soh HJ; Nataraja RM; Pacilli M
J Pediatr Surg; 2018 Dec; 53(12):2423-2429. PubMed ID: 30236605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
